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Background: Currently, little is known about the types of evidence used by policy 
makers. This study aimed to investigate how policy makers in the health domain use 
and evaluate evidence and how this differs from academic epidemiologists. By having 
a better understanding of how policy makers select, evaluate, and use evidence, aca-
demics can tailor the way in which that evidence is produced, potentially leading to more 
effective knowledge translation.
Methods: An exploratory mixed-methods study design was used. Quantitative measures 
were collected via an anonymous online survey (n = 28), with sampling from three health- 
related government and non-government organizations. Semi-structured interviews with 
policy makers (n = 20) and epidemiologists (n = 6) were conducted to gather qualitative data.
results: Policy makers indicated systematic reviews were the preferred research 
resource (19%), followed closely by qualitative research (16%). Neither policy makers 
nor epidemiologists used grading instruments to evaluate evidence. In the web survey, 
policy makers reported that consistency and strength of evidence (93%), the quality 
of data (93%), bias in the evidence (79%), and recency of evidence (79%) were the 
most important factors taken into consideration when evaluating the available evidence. 
The same results were found in the qualitative interviews. Epidemiologists focused on 
the methodology used in the study. The most cited barriers to using robust evidence, 
according to policy makers, were political considerations (60%), time limitations (55%), 
funding (50%), and research not being applicable to current policies (50%).
conclusion: The policy maker’s investigation did not report a systematic approach to 
evaluating evidence. Although there was some overlap between what policy makers 
and epidemiologists identified as high-quality evidence, there was also some important 
differences. This suggests that the best scientific evidence may not routinely be used in 
the development of policy. In essence, the policy-making process relied on other juris-
dictions’ policies and the opinions of internal staff members as primary evidence sources 
to inform policy decisions. Findings of this study suggest that efforts should be directed 
toward making scientific information more systematically available to policy makers.
Keywords: policy making, knowledge translation, evidence-based practice, government, mixed-methods research
Abbreviations: ACT, Australian Capital Territory; EBM, evidence-based medicine; HREC, Human Research Ethics Committee; 
KT, knowledge translation; RCT, randomized controlled trial; NGO, non-government organization.
2Jenkins et al. Evaluating and Using Observational Evidence
Frontiers in Public Health | www.frontiersin.org December 2016 | Volume 4 | Article 267
inTrODUcTiOn
There has been increasing discussion that in order to improve 
public health outcomes quality scientific research should be used 
throughout the development of health policies (1). The process 
of disseminating academic research to policy makers is referred 
to as knowledge translation (KT) or knowledge exchange (2). 
The process of KT involves many activities and specific practices, 
including producing synthesized research aimed at informing 
policy, writing plain language summaries of findings, and spend-
ing time with users to understand their context and research 
needs (3). It is believed that if KT is done effectively then the 
use of scientific evidence in policy and practice decisions will be 
increased (4).
In the “real world” of policy making, scientific research is 
just one of many types of information used (5). Policy makers 
interpret and “use” evidence in a broad sense (e.g., non-research 
data such as public health surveillance data and strategic needs 
assessments) (6). There is also a range of political, economic, and 
social drivers which affect decisions during policy development. 
In order to support a particular policy agenda, while also manag-
ing the competing interests of diverse stakeholders, policy makers 
may use specific information without giving consideration to all 
the available evidence (4, 7) or may not be able to directly trans-
late the findings, or recommendations, from epidemiological 
research into action within their particular context (8).
Previous research has focused on the apparently low uptake 
of academic research by policy makers, with particular attention 
given to understanding how and under what circumstances 
policy makers access and use academic evidence (9). However, 
the needs and practices of policy makers are rarely the subject of 
rigorous study and are likely to be more complex and nuanced 
than can be captured in surveys (6). For example, three system-
atic reviews (10–12) discussed the facilitators and barriers to 
the use of evidence in policy making and identified that policy 
makers use a broad range of evidence. These studies could not 
find reliable evidence of how much policy makers use academic 
research in the policy making process or how the definition of 
evidence by policy makers differs from the conceptualization of 
what is classified as evidence by researchers. As such, we require 
a clearer understanding of how policy makers define and use 
evidence (13).
Currently, little is known about what types of information 
and evidence is normally used as part of the policy development 
process or the extent to which political agendas and budgetary 
constraints influence the design and choice of policy options (6, 9, 
14). In one of the few studies investigating the sources of research 
evidence that policy makers in government accessed when mak-
ing a decision, academic literature was one of the least frequently 
used sources, along with internal expertise, policy documents, 
and employing a consultant (15). A study by Head et  al. (9) 
found that the most valued source was the knowledge of their 
immediate colleagues (93%). Their study also found that over 
40% of policy makers reported that academic research was used 
in informing policy and legitimizing policy choices. However, 
the majority also stated that policy making was overwhelmingly 
driven by budgetary considerations (83%), political acceptability 
of decision (80%) and responding to urgent day-to-day issues 
rather than “long-term” thinking (75%) (9).
By investigating the type of research that policy makers 
use to inform policy decisions, how they identify evidence 
and what other factors may influence policy decisions, we 
can identify what information is viewed as more relevant and 
timely (6). This may contribute to researchers better tailoring 
their research to policy maker’s needs and thus improving KT 
processes and the take up of scientific evidence in the policy 
development process.
There is also a need to investigate how policy makers select and 
evaluate the quality of evidence. One way of selecting and evalu-
ating evidence is by using an “evidence hierarchy.” This hierarchy 
may consider certain types of experimental research, for example 
randomized controlled trials (RCTs) and systematic reviews of 
RCTs, as highest in methodological quality (16). Researchers and 
clinicians use particular grading instruments to grade the quality 
of evidence. An example of such an instrument is Grading of 
Recommendations, Assessment, Development and Evaluation, 
which evaluates biomedical evidence based on risk, burden, and 
cost of intervention (17).
Although the use of evidence hierarchy and grading systems 
may provide an easier, or at least more streamlined, way of 
identifying high-quality evidence, in many situations RCTs may 
not be the most appropriate research methodology to answer 
specific policy questions, particularly in the sphere of public 
health. For example, findings from RCTs do not usually take 
into account the political, social, or economic context (18–20). 
RCTs may also not be a practical, or ethical, research option 
(e.g., research in smoking, HIV, or dementia) (21). Finally, 
the results of RCTs may not be easily applied to the general 
population or specific individuals (22). Due to these factors, 
policy makers often use a different hierarchy of evidence than 
researchers (23). For example, policy makers may consider the 
strongest evidence to be that from systematic reviews as they 
provide an overview of scientific studies which meet explicit 
criteria. Yet, single studies and evaluations are more commonly 
used to support policy than systematic reviews, possibly because 
systematic reviews are not available due to time constraints or 
lack of sufficient evidence (23).
Epidemiological data and research is typically valued highly 
as “objective” or “hard” data compared to qualitative data or case 
studies (24). Findings derived from epidemiological research 
are perceived to be most relevant indicator of adverse effects in 
humans (25) and inform public health, such as health promotion 
and health policy and planning (26). Public health practice is 
mostly based on observational epidemiological research, such 
as cohort, case-control, and cross-sectional studies, rather than 
RCTs (27). Observational epidemiological research has multiple 
advantages, for example a large sample size and longer follow-
up periods. It can also provide a powerful argument for change 
by using local data and can impact policy to address emerging 
public health problems (28). However, epidemiological findings 
may not be in a form that is useful or easily understood by policy 
makers, for example lengthy research reports with data at a state 
or country level (20) or policy makers may be hesitant to use it 
due to chance of bias and confounding (29).
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Given the importance of promptly incorporating new and 
robust scientific evidence into policy and the barriers to KT 
identified above, there is an urgent need to better understand 
how policy makers evaluate and use evidence. Therefore, the 
current study had two intersecting aims. The first aim was to 
gain an understanding of the role of research evidence in policy 
making. The second was to investigate how policy makers in the 
health domain select this evidence and whether they systemati-
cally assess evidence quality and how this differs from academic 
epidemiologists.
MaTerials anD MeThODs
An exploratory mixed-methods study design was used in order to 
provide a deeper understanding. The design involved the collec-
tion and data analysis of two sets of qualitative interviews (n = 13 
and 6) and one quantitative survey (n =  28). Both interviews 
and survey are included in Supplementary Material. Written 
informed consent was obtained from all participants prior to 
involvement in the study. The Australian National University 
Human Research Ethics Committee (HREC) and the Australian 
Capital Territory (ACT) Health HREC Survey Resource Group 
approved the study.
Qualitative interviews with Policy Makers
Participants and Recruitment
The first set of interviews focused on a purposive heterogene-
ous sample of 20 people who worked in policy. Thirteen par-
ticipants were from the ACT Government Health Directorate, 
four participants were from non-governmental organizations, 
one from a national Australian government department, and 
two from Australia’s peak research funding body, the National 
Health and Medical Research Council. Individuals were invited 
to participate in the study if they had any previous experience 
contributing to the development and implementation of health 
policy or programs relating to risk factors for chronic disease, 
mental health, or aging. Executive Directors from ACT Health 
identified participants and invited them via email to participate. 
Individuals who responded and consented to participating 
were then contacted by the ANU researchers. Participants were 
selected irrespective of policy background, time spent in organi-
zational roles, or seniority. Participants from ACT Health were 
from a wide range of policy units, including Women’s Youth and 
Child Health; Aboriginal and Torres Strait Islander; Alcohol and 
Other Drugs; Rehabilitation, Aged and Community Care; and 
Population Health.
Measures
One-on-one semi structured interviews were conducted with 
participants focusing on understanding: (1) how policy makers 
locate and use evidence from observational and other research; 
(2) factors influencing their choice of evidence sources; (3) how 
policy makers deal with conflicting evidence from specific top-
ics; (4) how policy makers evaluate the quality of research; and 
(5) how policy makers view researchers. The interviews also sought 
information on perceived barriers to KT. The interview questions 
were developed in consultation with research experts and senior 
staff from the health department, Alzheimer’s Australia, and 
NHMRC. Interviews were recorded and transcribed. Interviews 
were done one-on-one and took approximately 1 h.
Analysis
The transcribed interviews were uploaded into NVivo (30) 
and thematically analyzed for themes. These themes included 
evidence sources, choice of evidence sources, confusion about 
policy, evaluating policy, grading evidence, policy drivers, 
policy process, policy maker concerns, and barriers affecting KT. 
Average and percentage calculations were also applied.
Qualitative interviews with 
epidemiologists
Participants and Recruitment
The second set of interviews focused on a purposive sample 
of chronic disease experts, known to the authors, who were 
approached to provide their views regarding the characteristics 
of high-quality observational research, their opinion about the 
currently available evidence rating systems, and the implications 
of grading observational research.
Measures
Participants were asked to answer seven open-ended questions 
in paper form seeking their views on: (1) their opinion of what 
constitutes high-quality observational research and how it com-
pares with other types of research; (2) their understanding and 
use of current rating systems for grading evidence; and (3) the 
consequences of inappropriately rating observational research. 
Participants were provided with a one-page guide to grading 
instruments to clarify what the authors defined as a grading 
instrument (included in Supplementary Material).
Analysis
Thematic analysis using a step by step process was conducted to 
analyze the interviews. The interview transcripts were repeat-
edly screened in order to identify a list of recurring themes that 
appeared critical to evaluating evidence. These themes included 
evidence sources, choice of evidence sources, evaluating evi-
dence, grading evidence, and observational research. Average 
and percentage calculations were also applied.
Quantitative survey
Participants and Recruitment
An anonymous survey was compiled using the online survey tool 
Qualtrics (31). Senior staff from three health-related organiza-
tions, two government and one non-government, invited all 
policy makers via email to complete the survey. The selection 
of participation was not reliant on age, gender, or policy experi-
ence; however, the survey was only distributed to staff who were 
not involved in the qualitative interviews. Participants were not 
offered any incentives for completing the survey. The survey was 
accessible to participants for 6  months. In the time the survey 
was accessible, 58 participants began the survey, but only 28 
participants provided responses to all questions.
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Measures
The focus of the survey was barriers to knowledge-uptake, 
knowledge needs at the time of the survey, and the accessibility 
of information. The survey comprised 18 questions. Of these 
six were multiple-choice, five were rating scales, six were open-
ended, and one was a combination of multiple-choice and open 
ended (included in Supplementary Material). The questions in 
the survey were developed after examination of surveys that had 
been used in related studies, consideration of results of the quali-
tative interviews, and after consultation with collaborators from 
the University, the Health Department and Alzheimer’s Australia.
Analysis
Participants with missing data were excluded at the item level. 
Data were analyzed using Microsoft Excel. Descriptive statistics 
and bar graphs were used to illustrate response patterns to survey 
items.
resUlTs
Qualitative interviews with Policy Makers
All but one participant (95%) reported that policies and program 
decisions were often based on work, including current programs 
or policies, which had been done in other jurisdictions or by 
other organizations that were presumed to have better resources 
for seeking evidence (e.g., work tendered to university research-
ers, larger organizations). In this context, respondents reported 
that greater emphasis was placed on the experience of running 
the program or implementing the policy than on the evidence 
base behind it, which was typically not systematically checked. 
As an example, one participant noted a program implemented 
in another state that was “taken up” and resulted in a lot of prob-
lems. Subsequent contact with those who had set up the original 
program revealed that they too had had a lot of problems but had 
not reported them.
No respondents identified a systematic approach to gathering 
evidence for policy. Fourteen participants (70%) mentioned that 
part of their research strategy included talking to experts, includ-
ing academics and consultants. Eleven participants (55%) gained 
most of their information from consumer input and subscribed 
to publications by the Australian Healthcare and Hospitals 
Association. Academic journals and Institutional research/
library services were only used by five participants (25%).
Twelve participants (60%) mentioned politics or political 
agenda as a significant contributor to the policy formation pro-
cess. The political agenda may drive what research is used and is 
not, regardless of the quality of the research. For example, one 
participant said “… the politicians are wanting to say ‘we’ve made 
a decision, this is what we’re going to do’… and if there are votes in it 
[the politicians] will do it regardless of the evidence” (Government 
Health Middle Manager). Eleven participants (55%) also cited 
that consumer or community views were another policy driver.
Eight participants (40%) discussed that there was not a great 
understanding of what constitutes good or strong evidence. For 
example, one participant said “I think it’s a bit of an issue that 
we’ve seen in terms of being able to identify well what is good 
evidence, what’s real evidence, what evidence should you use for 
a policy …  what evidence should you be using to back that up. 
Don’t just go to a website and copy something – that happens, 
you know, which is not very good but it happens” (Government 
Health Project Officer). Policy makers identified the following as 
the most common factors which affect evidence choice: the type 
of evidence (60%), the reputation of the evidence source (55%), 
quality of the evidence (45%), and local applicability (40%).
Only three participants (15%) knew of grading systems and 
they did not use grading systems to evaluate evidence. Two of 
these participants discussed the mismatch between grading 
systems and policy, with RCTs not necessarily being applicable 
in the policy decision-making, but rather social research being 
more likely to inform a policy decision. One of the participants 
highlighted this mismatch and the use of systematic reviews, stat-
ing: “it’s hard to find any RCTs for the issues we’re after and whether 
they’re appropriate anyway in some contexts … in terms of policy 
what’s really good is a Cochrane review or something that’s looked 
at a bunch of things across everywhere and synthesized it and so 
then you can look at what the general opinion or picture looks like” 
(Government Health Middle Manager).
The most cited barriers to using robust evidence were political 
agenda (60%), time limits (55%), funding (50%), and research 
not being applicable for current policies (50%). For example, 
one participant stated “research takes time, as well as money and 
effort …. Policies have a different timeframe. So if a government is 
going to move in a particular area, or feels inclined or compelled 
that it needs to come up with something, it might not be able to 
wait for research” (Government Health Senior Manager) Two 
participants also stated that government department employees 
were risk averse and so would “perpetuate current practice” 
rather than suggesting and evaluating “original ideas” based on 
new research.
When policy makers were asked what could improve the use of 
evidence in developing policy, six participants (30%) stated that 
there should be more “links” or collaborations between govern-
ment staff and researchers. According to one policy maker these 
linkages “would make policy development a lot easier because you 
would have shown quite clearly due to the collaborative nature of 
the research that you’ve considered a large number of things and it 
would seem to provide a very solid finding because of that” (NGO 
Manager). Two participants (10%) stated that being able to access 
collated information would be helpful as it would reduce the 
amount of time spent looking for applicable research.
Qualitative interviews with 
epidemiologists
Seven epidemiologists were asked to participate; however, only 
six agreed and completed the interview. All interviewees had a 
post-doctoral degree, and all but one was a researcher from an 
Australian university. There was an even number of male and 
female respondents.
All respondents cited that they had heard of grading system 
but tended not to use them to evaluate research evidence, rather 
they had their own way of evaluating evidence. One participant 
stated that they evaluated studies from first principles (clearly 
defined research question, clear and appropriate methods, high 
participation rates, appropriate analysis, and conclusions), and 
FigUre 1 | The most important factors taken into consideration when 
evaluating evidence.
FigUre 2 | The relative quality of specific research methods and data 
synthesis techniques.
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another admitted to giving more credibility to studies published 
in prestigious journals as they tended to undergo more rigorous 
peer-review and methodological editing.
All respondents cited that although RCTs are considered at 
the top of the hierarchy of evidence and observational research 
lower, RCTs are not necessarily the most efficient or applicable 
evidence. Respondents found several problems with using RCTs, 
including unsuitable research questions (e.g., environmental and 
health-related research questions), limited generalizability, and 
bias. All respondents argued that it is more important to look at 
the design and conduct of the study – for example cohort size, 
duration, evaluation of relevant covariates/confounders – than it 
is to look at what rating the evidence is.
Responses to what constituted as high-quality observational 
research all focused on the rigor of the methodology. All respond-
ents agreed that high-quality observational research should 
address bias and ensure that the data are valid. Four respondents 
also argued that the sample had to be representative of the target 
population and large.
Quantitative survey with Policy Makers
The majority of respondents were aged between 35 and 44 years 
(32%) followed closely by 45–54 (29%) and 55–64 years (25%). 
Respondents were mostly female (71%) and had completed a 
postgraduate qualification (82%). Of the 28 participants who 
responded to all questions, 13 (46%) described their level within 
the organization as “middle management or project/policy officer 
with some management responsibilities.”
When asked to indicate preferred research methods, respond-
ents (19%) indicated that systematic reviews were the preferred 
research method. Qualitative research and RCTs followed with 
response rates of 16 and 13% respectively. Only 7% of respond-
ents indicated a preference for observational research.
The most easily understood sources of evidence were trusted 
organizations (96%), other internal staff (92%), consumer views 
(85%), policies from other jurisdictions (81%), and expert opin-
ions (73%). The most difficult evidence sources to understand 
were researchers and existing academic research (42%) and 
internal statistical data (35%).
The most important factors taken into consideration when 
evaluating evidence are shown in Figure  1. When asked to 
identify how often evidence sources were utilized in the policy 
process, the subset of policy makers (40%) who responded to this 
question indicated that the most often used policy sources were: 
existing academic research (92%), other staff within the organi-
zation (92%), similar policy experience from other jurisdictions 
(85%), publications from trusted organizations (73%), and guide-
lines (58%). The majority of policy makers from the government 
health department (61%) indicated that they had not used their 
own departmental epidemiological reports in formulating new 
population health-relevant policy.
The relative ranking of specific research methods and data 
synthesis techniques, as indicated by policy makers, is shown 
in Figure 2. Policy makers’ responses to the open-ended ques-
tion of what (in their opinion) constitutes high-quality forms of 
evidence varied. Some responses included: articles published in 
reputable peer-reviewed journals, RCTs that can be related to and 
translated into practical clinical guidelines, systematic reviews, 
case studies (depending upon the research question), and sound 
methodology, clearly articulated, and peer reviewed research.
DiscUssiOn
The aims of this study were to gain an understanding of the role 
of research evidence in policy making, investigate how policy 
makers in the health domain select this evidence, and whether 
they systematically assess evidence quality. While use of evidence 
differs somewhat across policy makers, it appears that the reliance 
on direct scientific evidence in the policy development process 
is low. The policy maker’s investigation did not seem to have a 
methodical approach to evaluating evidence. Although there was 
some overlap between what policy makers and epidemiologists 
identified as high-quality evidence, there was also some impor-
tant differences which suggests that the best scientific evidence 
is not frequently used in the development of policy. Differences 
between epidemiologists and policy makers included the way 
evidence was evaluated and the importance placed on study’s 
methodology.
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What evidence Do Policy Makers Use in 
the Policy Process?
Systematic reviews were the preferred research method in the 
policy-making process. Observational research came last and 
ranked as the lowest quality. Previous research has found that 
policy makers perceived systematic reviews as better suited 
to identifying gaps in existing research rather than providing 
answers to policy questions (32). This research also found that 
systematic reviews were useful only when they had been commis-
sioned to support policy decisions that had already been made, 
rather than inform the decision-making process of which policy 
option is most effective. Systematic reviews may be favored by 
policy actors because of their potential to save time and other 
resources and are seen as a credible source of information.
The information provided by policy makers about the use of 
academic resources in the policy process is inconsistent. In the 
web survey, all responding participants indicated that academic 
research was the most often utilized evidence source in the 
policy process. However, in the interviews, only one-quarter of 
participants stated that they referred to academic journals when 
gathering evidence for policy. Furthermore, participants from the 
web survey stated that academics and existing academic research 
were the most difficult evidence source to understand. This dif-
ference between responses may indicate that what policy makers 
think they are using, or what they should ideally be using, is not 
what they actually use and that they may not fully understand the 
academic research that they are using. Studies that had similar 
results found that respondents did not use academic literature 
because they did not have access to libraries or online journals, 
they were not trained in how to use academic search engines and 
because they found academic literature complex and frequently 
contradictory (15).
Results from both the web survey and interviews found that 
the majority of policy makers used work which had been done by 
other jurisdictions or organizations as a base for policy and pro-
gram decisions. The use of other jurisdictions programs/policies 
may be a feasible option as it fits with the policy environment and 
provides a sense of security that the intended outcomes will be 
achieved within the decided timelines. However, as participants 
pointed out, this transferability either may not be applicable to 
the adopting jurisdiction or key information and supporting 
evidence may not be provided by the other jurisdiction. Given 
that respondents stated they usually did not check the quality 
of the evidence to these programs, or the applicability of this 
evidence to the situation, then the policy/program objective may 
not be met.
Respondents from both the interviews and web survey also 
mentioned that other internal staff members were one of the 
most frequently utilized source of evidence, and that part of their 
research strategy included talking to others, such as experts or 
consultants. This has been found in previous studies and may be 
a way of gaining accurate information quickly (9, 14, 33).
Policy maker’s reliance on peers and other jurisdictions, 
rather than evidence, could indicate several possible characteris-
tics of policy makers. First, this might suggest that respondents 
are assuming that someone else has checked and evaluated the 
evidence. Second, policy makers may lack the skills to evaluate 
the evidence themselves, or lack confidence in their own skills. 
A third possibility, cited by two participants, is that individu-
als within the government health department are risk averse. 
Individuals may feel that the culture within the public service 
discourages innovative programs and policies as such evaluations 
may fail and result in damage to the government and individual’s 
reputations.
Previous research has found that political opinion or targets 
influenced the adoption of particular policies or programs (13). 
Within this study, most policy makers mentioned politics or 
political agenda as a significant driver in the policy formation 
process, followed closely by consumer or community views. 
In Ritter’s study (15), they found that the internet, notably 
“Google,” and statistical data were the third and fourth most 
frequently mentioned source used by policy makers. Policy 
makers did not mention the use of the internet in our quan-
titative survey, and only one participant mentioned it in the 
qualitative interviews. The majority of respondents in our 
study indicated that they did not use their own departmental 
epidemiological reports. Our results may differ from Ritter’s 
because we did not explicitly ask about internet or statistical 
data use or because participants were hesitant to discuss their 
usage of these sources.
how Do Policy Makers evaluate the 
Quality of evidence and how Does it 
compare to epidemiologist’s evaluation?
Just under half of participants in the interviews discussed that 
there was not a great understanding among policy makers 
of what makes good quality evidence. This has been found in 
previous studies (23). Although some respondents had heard 
of grading systems, neither the policy makers nor epidemiolo-
gists whom we interviewed used them. Rather, policy makers 
and epidemiologists had their own way of evaluating evidence. 
Although grading systems may not identify the most appropri-
ate research methodology, their usage enables a standardized, 
comprehensive, transparent, and easily communicated way of 
rating the quality of evidence for different policy decisions and 
the strength of recommendations and could improve decision-
making processes (34).
Both parties agreed that RCTs, followed by systematic reviews, 
provided the highest quality evidence and that observational 
research was ranked the lowest. However, both policy makers 
and epidemiologists cited problems with using RCTs in their 
respective fields. For policy makers, RCTs were not applicable 
in the policy decision-making process, whereas epidemiolo-
gists had methodological issues with RCT designs (e.g., limited 
generalizability and bias). These findings are similar to previous 
research (20, 23).
Barriers to Use of evidence in 
Policy Making
The most cited barrier to using robust evidence was political 
agenda and time limits. Previous research has also found that the 
short time periods, or need for action, within the policy making 
sphere meant that decisions were often made whether “strong” 
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evidence was there or not (13, 35). Research can take up to 3 years 
to be published following data collection, so by the time it is made 
available the information may be out of date or less useful to 
policy makers (4).
Half of our policy-maker participants stated that barriers to 
using research were lack of funding and research not being appli-
cable to current policy. This has been found in previous research 
(35, 36). It has been suggested that in order to overcome these 
barriers there should be a dialog between researchers and policy 
makers before the study design is carried out. As policy decisions 
may be influenced by pragmatic considerations, such as cost (13), 
then, researchers should be made aware of these considerations 
and build research and recommendations that accommodate 
them.
enablers to Use of evidence in 
Policy Making
The establishment of more links, or collaborations, between 
policy makers and researchers was cited by one-third of policy 
makers as a way to improve the use of evidence in the policy-
making process. This strategy has been frequently discussed in 
previous research (7, 35). Previous research has identified that 
policy makers use sources that are highly accessible and prefer 
summative information that uses plain language and clear data 
(7, 15). Two policy makers in our study discussed having access 
to evidence collated within a single source. We think this type of 
information source would not only reduce the amount of time 
policy makers spend gathering evidence but could also be used 
to help policy makers identify strong evidence, based on the 
methodological considerations discussed by epidemiologists in 
this study. The authors have developed a web-based tool designed 
to help policy makers find and evaluate evidence (37). This 
tool will integrate the epidemiologists and policy makers on 
observational evidence and provide policy makers with the skills 
needed to understand and critically appraise research, which is 
a specific practice of KT (3).
This study has some limitations. First, the sample size was 
small and only a few organizations within a single Australian 
provincial-level jurisdiction were surveyed and as such may 
not be more widely generalized. Second, due to survey design, 
we could not analyze how policy maker’s level of research 
training affected their use of scientific research. For example, 
it is possible that those with a specific health-related Masters 
or Postgraduate degree are more likely to use peer reviewed 
literature. Despite these limitations, this study gathered data 
on a process about which little is known or understood. 
Furthermore, it used different methodologies in order to gain 
a more comprehensive understanding of the issue and different 




To facilitate the use and assessment of academic research in the 
policy-making process, we have four recommendations. The first 
is to build policy makers capacity to appraise evidence, through 
strategies, such as training and participation in internships. This 
recommendation is based on our finding that policy makers 
did not have a great understanding of what makes good qual-
ity evidence nor did they use a standardized way of evaluating 
evidence. As only a small number of policy makers in this study 
referred to academic sources, the second recommendation is to 
ensure that policy makers can access robust sources of scientific 
evidence, for example online peer-reviewed journals. Third, 
because the policy and scientific processes occur on different 
time scales, which policy makers in this study cited as a bar-
rier to using robust evidence, the sharing of evidence between 
researchers and public servants should be facilitated through 
new channels and ways of conducting business. This is particu-
larly important for health issues for which the scientific data may 
vary substantially over time. Finally, we recommend developing 
mechanisms through which scientists with specific expertise 
are invited into a particular department for a “scientific chat” 
to openly discuss planned policies. This would be particularly 
useful in cases where commissioning new research would take 
too long but where substantial “soft” evidence is already available 
in the scientific field.
For Researchers
Based on our findings that policy makers cited researchers 
and existing academic research as one of the most difficult 
evidence sources to understand and that a barrier to using 
robust evidence was research not being applicable to current 
policies, we have three recommendations for researchers. 
The first is to build awareness among researchers producing 
policy-relevant material that this information cannot be com-
municated exclusively through typical scientific dissemination 
processes (e.g., conference presentation, peer-reviewed publi-
cation). Furthermore, academic research with policy-relevant 
material should include a clearly identified policy-relevant 
section that can easily be identified by policy makers, and 
the language and statistics included should be tailored in a 
way that makes them usable by policy makers. Second, training 
on the production and effective ways to communicate policy-
relevant material in scientific research should be provided to 
researchers. Finally, forums where scientists and policy makers 
can interact and demonstrate their viability and effectiveness 
should be established.
cOnclUsiOn
This study has found that neither policy makers nor epidemi-
ologists are using grading systems to evaluate evidence, rather 
each have their own ways of assessing the evidence. Both policy 
makers and epidemiologists recognized that RCTs were usually 
at the top of these hierarchies, but that RCTs were not always the 
most efficient or applicable evidence upon which to base popu-
lation health policies and that there were some problems with 
RCT designs. Policy makers in this study demonstrated a good 
understanding that they need to have an evidence base, that it is 
an important part of the process, and that it justifies the policy. 
However, the time and resources to form that evidence base, as 
well as an understanding of what constitutes good evidence and 
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how to evaluate it was lacking. This study is limited by its small 
sample size; however, by having both in-depth interviews and 
the web survey we are provided with more and often conflicting 
information than previous research has found using just survey 
data. Finally, this study focused on the use of observational evi-
dence and interviewed only one type of public health researcher, 
academic epidemiologists. By using this approach, the authors 
have not examined the use of intervention research which 
provides direct evidence on how to produce change and which 
may be more relevant to policy makers (38). Findings from this 
study demonstrate that scientific information needs to be more 
systematically available to policy makers and that efforts should 
be directed toward increasing the communication between 
researchers and policy makers.
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